AM Investment Strategies LLC Takes Position in The Clorox Company (NYSE:CLX)

AM Investment Strategies LLC acquired a new stake in The Clorox Company (NYSE:CLXFree Report) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 1,481 shares of the company’s stock, valued at approximately $211,000.

Other hedge funds have also recently modified their holdings of the company. abrdn plc grew its position in shares of Clorox by 20.1% in the 4th quarter. abrdn plc now owns 198,250 shares of the company’s stock valued at $28,268,000 after buying an additional 33,135 shares during the last quarter. International Assets Investment Management LLC grew its position in shares of Clorox by 17,658.5% in the 4th quarter. International Assets Investment Management LLC now owns 484,453 shares of the company’s stock valued at $69,078,000 after buying an additional 481,725 shares during the last quarter. Adage Capital Partners GP L.L.C. purchased a new position in shares of Clorox in the 3rd quarter valued at $6,605,000. Eagle Rock Investment Company LLC purchased a new position in Clorox during the 4th quarter worth $2,940,000. Finally, Nordea Investment Management AB grew its position in Clorox by 4.0% during the 4th quarter. Nordea Investment Management AB now owns 9,551 shares of the company’s stock worth $1,362,000 after purchasing an additional 364 shares during the last quarter. 78.53% of the stock is owned by hedge funds and other institutional investors.

Clorox Price Performance

Shares of NYSE CLX traded down $0.27 during midday trading on Thursday, hitting $147.51. The company had a trading volume of 1,147,198 shares, compared to its average volume of 1,204,423. The company has a quick ratio of 0.57, a current ratio of 0.89 and a debt-to-equity ratio of 11.37. The Clorox Company has a twelve month low of $114.68 and a twelve month high of $178.21. The business has a 50-day simple moving average of $149.48 and a two-hundred day simple moving average of $142.31. The firm has a market capitalization of $18.31 billion, a price-to-earnings ratio of 234.15, a price-to-earnings-growth ratio of 2.31 and a beta of 0.43.

Clorox (NYSE:CLXGet Free Report) last announced its quarterly earnings data on Thursday, February 1st. The company reported $2.16 EPS for the quarter, beating the consensus estimate of $1.08 by $1.08. Clorox had a net margin of 1.09% and a return on equity of 319.41%. The firm had revenue of $1.99 billion during the quarter, compared to analysts’ expectations of $1.80 billion. During the same quarter last year, the business earned $0.98 earnings per share. The business’s revenue for the quarter was up 16.0% compared to the same quarter last year. Equities research analysts anticipate that The Clorox Company will post 5.52 earnings per share for the current year.

Clorox Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, May 10th. Investors of record on Wednesday, April 24th will be paid a $1.20 dividend. This represents a $4.80 annualized dividend and a dividend yield of 3.25%. The ex-dividend date of this dividend is Tuesday, April 23rd. Clorox’s dividend payout ratio (DPR) is 761.92%.

Analyst Ratings Changes

CLX has been the topic of several research reports. Jefferies Financial Group raised shares of Clorox from an “underperform” rating to a “hold” rating and set a $145.00 price objective on the stock in a research report on Tuesday, March 26th. JPMorgan Chase & Co. raised their price objective on shares of Clorox from $145.00 to $152.00 and gave the stock a “neutral” rating in a research report on Thursday, January 18th. Barclays lowered their price objective on shares of Clorox from $148.00 to $136.00 and set an “underweight” rating on the stock in a research report on Wednesday, April 10th. Deutsche Bank Aktiengesellschaft lowered their price objective on shares of Clorox from $155.00 to $151.00 and set a “hold” rating on the stock in a research report on Wednesday, April 17th. Finally, Citigroup lowered their target price on shares of Clorox from $165.00 to $155.00 and set a “neutral” rating on the stock in a report on Tuesday, April 16th. Four investment analysts have rated the stock with a sell rating and thirteen have assigned a hold rating to the company. According to MarketBeat, Clorox currently has a consensus rating of “Hold” and an average price target of $148.63.

Read Our Latest Research Report on CLX

Clorox Profile

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

See Also

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLXFree Report).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.